0
0

Department of Health and Human Services Awarded a Contract to GENSCRIPT USA INC for $14,979.75

Signed on

8/29/2024, 12:00 AM

GENSCRIPT USA INC Government Contract #75N93024P01064

GENSCRIPT USA INC was awarded a contract with the United States Government for $14,979.75. The contract was awarded by the agency office NATIONAL INSTITUTES OF HEALTH NIAID, which is a division with the National Institutes of Health within the Department of Health and Human Services.

Summary of Award

GENSCRIPT USA INC is a U.S.-owned business based in Piscataway, New Jersey. They were awarded a contract by the Department of Health and Human Services, specifically the National Institutes of Health, for laboratory testing services worth $14,979.75. One notable transaction involved an expenditure of -$1,235.25 on May 21, 2026.

Contract Details

Contract ID75N93024P01064
Contract TypeB
Total Obligation$14,979.75
Exercised Options$14,979.75
Base Amount + Options$14,979.75
Date Signed2024-08-29
Contract DescriptionGENSCRIPT USA INCORPORATED MONOCLONAL ANTIBODIES AND PLASMIDS SERVICES
Start Date2024-08-29
End Date2025-08-27

Agency Details

Awarding AgencyDepartment of Health and Human Services
Awarding Sub AgencyNational Institutes of Health
Awarding OfficeNATIONAL INSTITUTES OF HEALTH NIAID
Funding AgencyDepartment of Health and Human Services
Funding Sub AgencyNational Institutes of Health
Funding OfficeNATIONAL INSTITUTES OF HEALTH NIAID

Recipient Details

RecipientGENSCRIPT USA INC
Recipient Location860 CENTENNIAL AVE PISCATAWAY NEW JERSEY, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #P00001$-1,235.25May 21, 2026

National Institutes of Health, a sub agency of Department of Health and Human Services, issued a payment of $-1,235.25 to GENSCRIPT USA INC. The payment included a Subsidy Cost of $0.00.

This payment could indicate a change to the existing contract.

Transaction #0$16,215.00August 29, 2024

National Institutes of Health, a sub agency of Department of Health and Human Services, issued a payment of $16,215.00 to GENSCRIPT USA INC. The payment included a Subsidy Cost of $0.00.

Latest Bills

A bill to transfer administrative jurisdiction over certain parcels of Federal land in Harpers Ferry, West Virginia, and for other purposes.
Bill S 2280May 27, 2026
Language Access Board Act of 2026
Bill HR 8604May 27, 2026
Vote by Mail Protection Act of 2026
Bill HR 8666May 27, 2026
Expressing support for the designation of May 4, 2026, as a "National Day of Reason" and recognizing the central importance of reason in the betterment of humanity.
Bill HRES 1266May 27, 2026
Supporting the designation of the month of May as "Lyme and Tick-borne Disease Awareness Month".
Bill HRES 1279May 27, 2026
FIGHT Act of 2026
Bill HR 8723May 27, 2026
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Credit Reporting; File Disclosure".
Bill HJRES 184May 27, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Fair Credit Reporting; File Disclosure".
Bill SJRES 127May 27, 2026
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2024-03: Unlawful and Unenforceable Contract Terms and Conditions".
Bill HJRES 185May 27, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Consumer Financial Protection Circular 2024-03: Unlawful and Unenforceable Contract Terms and Conditions".
Bill SJRES 128May 27, 2026